Product Images Duloxetine Delayed-release Delayed-release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Duloxetine Delayed-release Delayed-release NDC 53217-130 by Aidarex Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - duloxetine dr usp 1
Figure 1 - duloxetine dr usp 2
Figure 2 - duloxetine dr usp 3
The given text represents a graph showing the proportion of patients who had a relapse after treatment with Duloxetine. The graph displays the percentage of patients who had a relapse on the Y-axis against the Time (in days) on the X-axis. There are five treatment options indicated on the graph with dosage given in mg. The graph can be used to evaluate the effectiveness of Duloxetine in preventing relapses among patients.*
Figure 3 - duloxetine dr usp 4
Figure 4 - duloxetine dr usp 5
Figure 7 - duloxetine dr usp 6
This text contains a chart showing the percentage of patients improved by a placebo and a medication called DUL at 601120 mg once daily. The chart shows the percent improvement in pain from baseline.*
Figure 8 - duloxetine dr usp 7
The text presents a chart showing the percentage of patients improved with placebo and a medication called DUL at 60 mg once daily, as well as the percentage of improvement in pain from baseline (BOCF). No further information is available to provide a more detailed description of the context or purpose of the chart.*
Figure 9 - duloxetine dr usp 8
This text shows a graph or table indicating the percentage of patients who improved after taking placebo and DUL (60/120 mg once daily). It also includes the percent improvement in pain from baseline. However, without context or additional information, the graph or table is not very informative.*
Image Description - duloxetine dr usp 9
This is a description of a medication called Duloxetine DR, USP, which is available in 60mg. It is a generic drug for Cymbalta and is packaged in 30 capsules. The NDC number is 53217-0130-30, and the lot number is mentioned several times. It is manufactured by Laboratorios DR. ESTEVE, S.A. in Spain. The text may indicate dosage instructions, but they are illegible. The last line refers to patient chart 106.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.